Allogeneic human cardiac stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic human cardiac stem cells, covering 2017-11-14 to 2017-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI [Phase 1, Phase 2]